Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Juri A. Giannotta"'
Autor:
Elisa Fermo, Cristina Vercellati, Anna Paola Marcello, Ebru Yilmaz Keskin, Silverio Perrotta, Anna Zaninoni, Valentina Brancaleoni, Alberto Zanella, Juri A. Giannotta, Wilma Barcellini, Paola Bianchi
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Congenital hemolytic anemias (CHAs) are heterogeneous and rare disorders caused by alterations in structure, membrane transport, metabolism, or red blood cell production. The pathophysiology of these diseases, in particular the rarest, is often poorl
Externí odkaz:
https://doaj.org/article/96eeaebcf4f543c6b7485b7d215fce35
Autor:
Anna Zaninoni, Juri A. Giannotta, Anna Gallì, Rosangela Artuso, Paola Bianchi, Luca Malcovati, Wilma Barcellini, Bruno Fattizzo
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Daratumumab is a monoclonal antibody directed against the transmembrane glycoprotein CD38 expressed on plasma cells and lymphoplasmocytes, with a proven efficacy in multiple myeloma. Here we show its clinical efficacy in a patient with cold agglutini
Externí odkaz:
https://doaj.org/article/7bcf3a9fff5e42d090ba02bb065b0b92
Autor:
Marco Capecchi, Giada Gazzola, Pasquale Agosti, Pasqualina De Leo, Ilaria Mancini, Barbara Ferrari, Juri Alessandro Giannotta, Andrea Artoni, Flora Peyvandi
Publikováno v:
Haematologica, Vol 109, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/894f8a576227424bb98fd6c34802e735
Autor:
Bruno Fattizzo, Valentina Carrai, Monica Crugnola, Erminia Baldacci, Marta Bellini, Costanza Bosi, Elisa Buzzatti, Domenica Caramazza, Giuseppe Carli, Monica Carpenedo, Cristina Clissa, Cristina Danesin, Maria Rosaria De Paolis, Juri Alessandro Giannotta, Vanessa Innao, Monia Marchetti, Uros Markovic, Alessandro Morotti, Mariasanta Napolitano, Andrea Patriarca, Loredana Pettine, Antonella Poloni, Elena Rivolti, Elena Rossi, Teresa Maria Santeremo, Cristina Santoro, Maria Elena Zannier, Francesco Zaja, Silvia Cantoni, Francesca Palandri, Valerio De Stefano
Publikováno v:
HemaSphere, Vol 7, p e024400a (2023)
Externí odkaz:
https://doaj.org/article/a80eb4b9d83b4b959bc96aa6ee514995
Autor:
Bruno Fattizzo, Marta Bortolotti, Juri Alessandro Giannotta, Dario Consonni, Silvia Cantoni, Wilma Barcellini
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Data concerning the efficacy of SARS-CoV-2 vaccines in patients with non-oncological hematologic conditions are lacking. These include autoimmune cytopenias (autoimmune hemolytic anemia AIHA, immune thrombocytopenia ITP, and autoimmune neutr
Externí odkaz:
https://doaj.org/article/2b55b1fe968642a4b24c55d41836ee30
Autor:
Bruno Fattizzo, Marta Bortolotti, Nicolò Rampi, Francesca Cavallaro, Juri Alessandro Giannotta, Cristina Bucelli, Ramona Cassin, Matteo Claudio Da Vià, Giulia Galassi, Alessandro Noto, Loredana Pettine, Francesca Gaia Rossi, Mariarita Sciumè, Ferruccio Ceriotti, Dario Consonni, Wilma Barcellini, Luca Baldini
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Hematologic patients show lower responses to SARS-CoV-2 vaccines, but predictors of seroconversion are lacking. In this prospective cohort study, hematologic patients undergoing SARS-CoV-2 mRNA vaccination at a single center in Milan, Italy, were sam
Externí odkaz:
https://doaj.org/article/797f5cc69ba94d6bb79dcbaf05eda072
Autor:
Bruno Fattizzo, Silvia Cantoni, Juri Alessandro Giannotta, Laura Bandiera, Rachele Zavaglia, Marta Bortolotti, Wilma Barcellini
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA) show good responses to frontline steroids. About two-third of cases relapse and require second-line treatment, including rituximab, mainly effective in AIHA, and thrombo
Externí odkaz:
https://doaj.org/article/05bf325446464621941860a999d758a7
Autor:
Bruno Fattizzo, Giorgia Virginia Levati, Juri Alessandro Giannotta, Giulio Cassanello, Lilla Marcella Cro, Anna Zaninoni, Marzia Barbieri, Giorgio Alberto Croci, Nicoletta Revelli, Wilma Barcellini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Low-risk myelodysplastic syndromes (LR-MDS) are a very heterogeneous disease, with extremely variable clinical features and outcome. Therapeutic strategies are still limited and mainly consist of erythropoiesis-stimulating agents (ESAs) and transfusi
Externí odkaz:
https://doaj.org/article/d5f012f1e2de4ebc9563150edf185ee7
Autor:
Bruno Fattizzo, Jessica Rosa, Juri Alessandro Giannotta, Luca Baldini, Nicola Stefano Fracchiolla
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
T-cell acute lymphoblastic leukemia/lymphoma is an aggressive hematological neoplasm whose classification is still based on immunophenotypic findings. Frontline treatment encompass high intensity combination chemotherapy with good overall survival; h
Externí odkaz:
https://doaj.org/article/73e1148955794234affd8b2dfe52a5e8
Autor:
Valeria Cortesi, Francesca Manzoni, Genny Raffaeli, Giacomo Cavallaro, Bruno Fattizzo, Giacomo Simeone Amelio, Silvia Gulden, Ilaria Amodeo, Juri Alessandro Giannotta, Fabio Mosca, Stefano Ghirardello
Publikováno v:
Diagnostics, Vol 11, Iss 9, p 1549 (2021)
Congenital hemolytic anemias (CHAs) are a group of diseases characterized by premature destruction of erythrocytes as a consequence of intrinsic red blood cells abnormalities. Suggestive features of CHAs are anemia and hemolysis, with high reticulocy
Externí odkaz:
https://doaj.org/article/5e9ea1bf6021478daf2d82ad17b65ba5